Inspire

© Reuters. On Tuesday, Inspire Medical Systems (NYSE:) received a new Overweight rating from Morgan Stanley, accompanied by a price target of $250. This initiation is based on the company's consistent performance and potential…

BITCOIN, CRYPTO KEY POINTS:READ MORE: Gold (XAU/USD) Prices Flirt with $2000 Level, Eyeing the FOMC Meeting for Fresh ImpetusBitcoin prices have taken a bit of a breather since the expansive rally that broke above the $35k mark last week…

Analysis of Nikkei (Japan 225)The Nikkei finished the first half of the year narrowly behind the Nasdaq as foreign investors piled onThe depreciation of the yen and the damage from US data to risk appetite sent the Nikkei lowerPossible…